Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karuna Mittal

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Medicinal Research Reviews|February 11, 2020
Spotlighting the hypoxia-centrosome amplification axisKaruna Mittal, Ritu Aneja
Cancers|September 11, 2019
Panoptic View of Prognostic Models for Personalized Breast Cancer ManagementGeetanjali Saini, Karuna Mittal, Padmashree Rida, et al.
Cell Cycle (Georgetown, Tex.)|July 8, 2015
Amplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinomaKaruna Mittal, Angela Ogden, Michelle D Reid, et al.
Journal of Clinical Pathology|August 25, 2019
Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situMichael Toss, Islam Miligy, Kylie Gorringe, et al.
Frontiers in Oncology|June 5, 2023
Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma David Dabbs, Karuna Mittal, Scott Heineman, et al.
British Journal of Cancer|March 24, 2017
Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancerKaruna Mittal, Shashi Donthamsetty, Ramneet Kaur, et al.
Histopathology|February 7, 2019
The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma in situMichael S Toss, Islam M Miligy, Rita Haj-Ahmad, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
CLO25-061: 7-Gene Biosignature Reclassified Women With DCIS Meeting NCCN Guideline (RTOG 9804-Like) Low-Risk Criteria as Molecular High RiskChirag Shah, Frank A Vicini, Eileen P Connolly, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 9, 2019
Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis studyMichael S Toss, Islam M Miligy, Kylie L Gorringe, et al.
Journal of Ovarian Research|March 20, 2016
A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomasKaruna Mittal, Da Hoon Choi, Sergey Klimov, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Medicinal Research Reviews|February 11, 2020
Spotlighting the hypoxia-centrosome amplification axisKaruna Mittal, Ritu Aneja
Cancers|September 11, 2019
Panoptic View of Prognostic Models for Personalized Breast Cancer ManagementGeetanjali Saini, Karuna Mittal, Padmashree Rida, et al.
Cell Cycle (Georgetown, Tex.)|July 8, 2015
Amplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinomaKaruna Mittal, Angela Ogden, Michelle D Reid, et al.
Journal of Clinical Pathology|August 25, 2019
Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situMichael Toss, Islam Miligy, Kylie Gorringe, et al.
Frontiers in Oncology|June 5, 2023
Analytical validation of the 7-gene biosignature for prediction of recurrence risk and radiation therapy benefit for breast ductal carcinoma David Dabbs, Karuna Mittal, Scott Heineman, et al.
British Journal of Cancer|March 24, 2017
Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancerKaruna Mittal, Shashi Donthamsetty, Ramneet Kaur, et al.
Histopathology|February 7, 2019
The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma in situMichael S Toss, Islam M Miligy, Rita Haj-Ahmad, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
CLO25-061: 7-Gene Biosignature Reclassified Women With DCIS Meeting NCCN Guideline (RTOG 9804-Like) Low-Risk Criteria as Molecular High RiskChirag Shah, Frank A Vicini, Eileen P Connolly, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 9, 2019
Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis studyMichael S Toss, Islam M Miligy, Kylie L Gorringe, et al.
Journal of Ovarian Research|March 20, 2016
A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomasKaruna Mittal, Da Hoon Choi, Sergey Klimov, et al.
Pageof 3